Modulation of the acquisition and expression of immunity by Tilorone: I. Delayed-type hypersensitivity responses

John R. Kettman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The chronic administration of Tilorone [(2,7-bis(diethylamino)ethoxy]fluoren-9-one) with antigen seems to prevent the generation of DTH effector cells. The administration of Tilorone proximal to DTH challenge blocks the expression of DTH. By local transfer of DTH effector cells, this latter effect can be shown to be due to the lack of nonspecific inflammatory cells. By the use of both systematic and local transfer systems, it is also shown that specific DTH effector cells from animals treated with Tilorone are unable to circulate in the normal manner. Overall, these experiments suggest that Tilorone does not block the generation of DTH effector cells, but it does greatly alter the expression of DTH. The relation between these effects and the known interferon induction capacity on Tilorone remains unclear.

Original languageEnglish (US)
Pages (from-to)21-28
Number of pages8
JournalImmunopharmacology
Volume1
Issue number1
DOIs
StatePublished - 1978

Fingerprint

Tilorone
Delayed Hypersensitivity
Immunity
Interferons
Antigens

Keywords

  • Delayed-type hypersensitivity
  • Tilorone

ASJC Scopus subject areas

  • Pharmacology

Cite this

Modulation of the acquisition and expression of immunity by Tilorone : I. Delayed-type hypersensitivity responses. / Kettman, John R.

In: Immunopharmacology, Vol. 1, No. 1, 1978, p. 21-28.

Research output: Contribution to journalArticle

@article{9f407455ff624df09c9ccf5d63d9357c,
title = "Modulation of the acquisition and expression of immunity by Tilorone: I. Delayed-type hypersensitivity responses",
abstract = "The chronic administration of Tilorone [(2,7-bis(diethylamino)ethoxy]fluoren-9-one) with antigen seems to prevent the generation of DTH effector cells. The administration of Tilorone proximal to DTH challenge blocks the expression of DTH. By local transfer of DTH effector cells, this latter effect can be shown to be due to the lack of nonspecific inflammatory cells. By the use of both systematic and local transfer systems, it is also shown that specific DTH effector cells from animals treated with Tilorone are unable to circulate in the normal manner. Overall, these experiments suggest that Tilorone does not block the generation of DTH effector cells, but it does greatly alter the expression of DTH. The relation between these effects and the known interferon induction capacity on Tilorone remains unclear.",
keywords = "Delayed-type hypersensitivity, Tilorone",
author = "Kettman, {John R.}",
year = "1978",
doi = "10.1016/0162-3109(78)90005-X",
language = "English (US)",
volume = "1",
pages = "21--28",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Modulation of the acquisition and expression of immunity by Tilorone

T2 - I. Delayed-type hypersensitivity responses

AU - Kettman, John R.

PY - 1978

Y1 - 1978

N2 - The chronic administration of Tilorone [(2,7-bis(diethylamino)ethoxy]fluoren-9-one) with antigen seems to prevent the generation of DTH effector cells. The administration of Tilorone proximal to DTH challenge blocks the expression of DTH. By local transfer of DTH effector cells, this latter effect can be shown to be due to the lack of nonspecific inflammatory cells. By the use of both systematic and local transfer systems, it is also shown that specific DTH effector cells from animals treated with Tilorone are unable to circulate in the normal manner. Overall, these experiments suggest that Tilorone does not block the generation of DTH effector cells, but it does greatly alter the expression of DTH. The relation between these effects and the known interferon induction capacity on Tilorone remains unclear.

AB - The chronic administration of Tilorone [(2,7-bis(diethylamino)ethoxy]fluoren-9-one) with antigen seems to prevent the generation of DTH effector cells. The administration of Tilorone proximal to DTH challenge blocks the expression of DTH. By local transfer of DTH effector cells, this latter effect can be shown to be due to the lack of nonspecific inflammatory cells. By the use of both systematic and local transfer systems, it is also shown that specific DTH effector cells from animals treated with Tilorone are unable to circulate in the normal manner. Overall, these experiments suggest that Tilorone does not block the generation of DTH effector cells, but it does greatly alter the expression of DTH. The relation between these effects and the known interferon induction capacity on Tilorone remains unclear.

KW - Delayed-type hypersensitivity

KW - Tilorone

UR - http://www.scopus.com/inward/record.url?scp=0018052416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018052416&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(78)90005-X

DO - 10.1016/0162-3109(78)90005-X

M3 - Article

C2 - 45786

AN - SCOPUS:0018052416

VL - 1

SP - 21

EP - 28

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 1

ER -